Suchergebnisse - "Wuerstlein, Rachel"

PubPharm (195)

21

Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers

enthalten in: Therapeutic advances in drug safety | 2023

von Schindler, F. | Schinkoethe, T. | Mahner, S. | +5

22

De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC) : Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Gluz, O. | Nitz, U. | Kolberg-Liedtke, C. | +23

CommentOn: Clin Cancer Res. 2022 Nov 14;28(22):4840-4842. - PMID 36083131

23

Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy

enthalten in: Breast care (Basel, Switzerland) | 2022

von Dimpfl, M. | Mayr, D. | Schmoeckel, E. | +4

24

Implementation of CDK4/6 Inhibitors and its Influence on the Treatment Landscape of Advanced Breast Cancer Patients - Data from the Real-World Registry PRAEGNANT

enthalten in: Geburtshilfe und Frauenheilkunde | 2022

von Engler, T. | Fasching, P. | Lüftner, D. | +30

25

Occurrence and characteristics of patients with de novo advanced breast cancer according to patient and tumor characteristics - A retrospective analysis of a real world registry

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Müller, V. | Hein, A. | Hartkopf, A. | +26

26

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

enthalten in: Breast cancer research : BCR | 2022

von Kolberg-Liedtke, C. | Feuerhake, F. | Garke, M. | +17

27

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

enthalten in: Breast cancer research | 2022

von Kolberg-Liedtke, C. | Feuerhake, F. | Garke, M. | +17

28

Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial

enthalten in: Breast cancer research | 2022

von Kolberg-Liedtke, C. | Feuerhake, F. | Garke, M. | +17

29

Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2022

von Pinato, D. | Ferrante, D. | Aguilar-Company, J. | +149

30

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting

enthalten in: International journal of molecular sciences | 2022

von Erber, R. | Angeloni, M. | Stöhr, R. | +23